MAP Medical Technologies
MAP Medical Technologies Oy, founded in 1991, is a part of Curium group. The mission of our company is to develop and manufacture radiopharmaceuticals which improve the quality and lenght of human life. The objective of our products is also to serve the needs of nuclear medicine professionals. Our highly devoted team and modern production facilities offer a unique setting for production of best quality pharmaceuticals.
We can provide to our customers and partners several radiopharmaceutical and radiochemical products and services in the field of nuclear medicine, for example:
- Generic radiopharmaceuticals like Mo-99/Tc-99m generator, iodine capsules for therapy and diagnosis, FDG and other products
- New diagnostic radiopharmaceuticals in close collaboration with our partners in prominent research institutions for such degenerative brain disorders like Parkinson's disease, Alzheimer's disease and others, which are related to activity and amount of neurotransmitters like dopamine, serotonin and others
We can offer our GMP facility and know how to other medical communities to test label and produce their own radiopharmaceutial compounds. We can create possibility a small scale manufacturing set up for the customer needs. With this unique set up we can save both money and time of the customer for example in production for clinical trial batch.
We see that a close collaboration with nuclear medicine professionals and full commitment to R&D will make the difference. Together we can help people to achieve better medical care with easy, reliable and cost effective manner. In fact, we are talking about people.
Research and development is the major cornerstone of our strategy for the future. We aim constantly to find solutions for better, medical care with the help of best quality pharmaceuticals. Read more about our R&D or to know about our publications.
More Materials About MAP Medical Technologies
Please contact Sales and Business Development Manager Aleksis Haukka.